European Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown, С. 117593 - 117593
Опубликована: Апрель 1, 2025
Язык: Английский
European Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown, С. 117593 - 117593
Опубликована: Апрель 1, 2025
Язык: Английский
European Journal of Medicinal Chemistry, Год журнала: 2025, Номер 287, С. 117328 - 117328
Опубликована: Фев. 2, 2025
Язык: Английский
Процитировано
1Molecules, Год журнала: 2025, Номер 30(5), С. 1095 - 1095
Опубликована: Фев. 27, 2025
Cancer remains a significant global public health challenge, with hepatocellular carcinoma (HCC) ranking among the top five malignancies in terms of mortality. Faberidilactone A, sesquiterpenoid dimer isolated from Inula japonica, exhibits potent cytotoxicity against various human tumor cell lines and demonstrates remarkable antitumor potential. In vitro studies using HepG2 cells revealed that faberidilactone A induces apoptosis ferroptosis, causes cycle arrest, enhances production intracellular reactive oxygen species (ROS), disrupts mitochondrial function. Mechanistic investigations via Western blot analysis indicated impedes proliferation by modulating signal transducer activator transcription 3 (STAT3) signaling pathway inhibits metastasis affecting focal adhesion kinase (FAK) pathway. vivo experiments zebrafish model demonstrated effectively suppresses dissemination anti-angiogenic properties. When concentration reached 10 µM, inhibition rates proliferation, migration, intersegmental vessels (ISVs) length were 76.9%, 72.6%, 46.2%, respectively. These findings underscore therapeutic potential as promising agent for HCC treatment.
Язык: Английский
Процитировано
1Bioorganic Chemistry, Год журнала: 2025, Номер unknown, С. 108392 - 108392
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0European Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown, С. 117593 - 117593
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0